| Announce Date | 01/30/2026 |
| EPS Normalized Actual | $10.34 (Miss by $-0.06) |
| EPS GAAP Actual | $10.34 (Miss by $-0.06) |
| Revenue Actual | $13.553B |
| Revenue Surprise | Beat by $13553M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $9.92851 |
| EPS GAAP Estimate | $9.92851 |
| Revenue Estimate | $13.703921268B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 54.5 | 4.37 | 53.5277 | 55.47191 | 5 |
| Dec 2028 | 60.8682 | 3.91 | 59.87036 | 61.66032 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 9.83 | 0.60435 | 13.553B | -1.79% | -190.7M |
| FQ2 2025 (Jun 2025) | 9.41 | 9.41 | 13.766B | 0.59% | 13766M |
| FQ1 2025 (Mar 2025) | 8.59 | 8.59 | 13.735B | 0.41% | 13735M |
| FQ4 2024 (Dec 2024) | 10.32 | 10.32 | 13.926B | 1.54% | 13926M |
| FQ3 2024 (Sep 2024) | 8.99 | 8.99 | 13.795B | 1.53% | 13795M |
| FQ2 2024 (Jun 2024) | 8.59 | 8.59 | 13.685B | 0.19% | 13685M |
| FQ1 2024 (Mar 2024) | 7.65 | 7.65 | 13.679B | 0.19% | 13679M |
| FQ4 2023 (Dec 2023) | 7.23 | 7.23 | 13.711B | 0.27% | 13711M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
9.92851
Consensus Revenue Estimates
13.703921268B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 10.943 | -- | 10.82262 | 11.09466 | 3 |
| FQ2 2027 (Jun 2027) | 11.0295 | -- | 10.90817 | 11.18236 | 5 |
| FQ1 2027 (Mar 2027) | 10.22825 | -- | 10.11574 | 10.37001 | 3 |
| FQ4 2026 (Dec 2026) | 11.37443 | -- | 11.30362 | 11.4787 | 1 |
| FQ3 2026 (Sep 2026) | 10.58147 | 7.1 | 10.51559 | 10.67847 | 1 |
| FQ2 2026 (Jun 2026) | 10.39634 | 9.49 | 10.33162 | 10.49165 | 1 |
| FQ1 2026 (Mar 2026) | 9.92851 | 13.48 | 9.13732 | 10.85478 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 15.26B | -- | 15.13B | 15.42B | 5 |
| FQ2 2027 (Jun 2027) | 15.21B | -- | 15.08B | 15.37B | 4 |
| FQ1 2027 (Mar 2027) | 15.18B | -- | 15.06B | 15.35B | 4 |
| FQ4 2026 (Dec 2026) | 14.55B | -- | 14.48B | 14.65B | 4 |
| FQ3 2026 (Sep 2026) | 14.25B | 4.86 | 14.18B | 14.35B | 4 |
| FQ2 2026 (Jun 2026) | 13.77B | 0.02 | 13.7B | 13.87B | 4 |
| FQ1 2026 (Mar 2026) | 13.7B | -0.23 | 13.66B | 13.78B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 9.22565 | 9.83 | 0.60435 | 6.15% |
| FQ2 2025 (Jun 2025) | 9.41 | 9.41 | 100% | |
| FQ1 2025 (Mar 2025) | 8.59 | 8.59 | 100% | |
| FQ4 2024 (Dec 2024) | 10.32 | 10.32 | 100% | |
| FQ3 2024 (Sep 2024) | 8.99 | 8.99 | 100% | |
| FQ2 2024 (Jun 2024) | 8.59 | 8.59 | 100% | |
| FQ1 2024 (Mar 2024) | 7.65 | 7.65 | 100% | |
| FQ4 2023 (Dec 2023) | 7.23 | 7.23 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $13.74B | $13.55B | $-190.7M | -1.41% |
| FQ2 2025 (Jun 2025) | $0B | $13.77B | $13766M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $13.74B | $13735M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $13.93B | $13926M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $13.8B | $13795M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $13.69B | $13685M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $13.68B | $13679M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $13.71B | $13711M | 100% |